financing

News

Lila Sciences' $235m first round, and other biofinancings

Recent biotech financings include big rounds for Lila Sciences, Odyssey, and Ollin, with ARTHEx, Dualitas, and YolTech also in on the action.

News

Heather Turner, LB Pharma's chief executive.

After a long biotech IPO lull, LB Pharma chances its arm

After a promising start, IPOs all but fizzled out this year, but LB Pharma is hoping that won't stymy its chances of completing a Nasdaq listing.

News

NRG raises £50m to start trials of Parkinson's, ALS drug

NRG Therapeutics' oversubscribed Series B will fund first-in-human trials of a drug targeting mitochondrial dysfunction in neurodegenerative diseases.

News

Treeline's $200m Series A extension, and other biofinancings

Recent biotech financings include a $200m round for Treeline, with Enveda, Wugen, CHARM Therapeutics, and MRM Health also in on the action.

News

Twin Health raises $53m, as study backs 'digital twin' AI

Twin Health has raised $53m to fund further rollout of its digital twin AI, shown to improve glucose control in diabetics in a just-published study.

News

Strand raises $153m for RNA meds, and other bio financings

Recent financings in biotech include a $153m Series B for programmable mRNA developer Strand, plus rounds for Artbio, Minghui, and Chai Discovery.

Lila Sciences' $235m first round, and other biofinancings

After a long biotech IPO lull, LB Pharma chances its arm

NRG raises £50m to start trials of Parkinson's, ALS drug

Treeline's $200m Series A extension, and other biofinancings

Twin Health raises $53m, as study backs 'digital twin' AI

Strand raises $153m for RNA meds, and other bio financings

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

financing

Editor's Picks